Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis [PDF]
Clinical Parkinsonism & Related DisordersIntroduction: Parkinson’s disease (PD) is associated with increased mortality risk (MR), reflecting progression of motor and nonmotor symptoms. PD psychosis (PDP), a common nonmotor symptom, increases with prolonged disease and elevates the MR of PD even
Stuart H. Isaacson +4 more
doaj +3 more sources
Off-label use of atypical antipsychotics- Where are we? [PDF]
European Psychiatry, 2023 Introduction Nowadays, In the exercise of psychiatric clinical activity, the prescription of atypical antipsychotics is a widespread practice. However, despite the approval in the treatment of psychoses and bipolar affective disorder, where its ...
R. P. Vaz +9 more
doaj +2 more sources
Association of typical and atypical antipsychotics with mortality in older adults with schizophrenia: a 5-year multicenter prospective study [PDF]
Brazilian Journal of PsychiatryObjective: Due to the uncertainty whether atypical and typical antipsychotics have a stronger association with mortality among older people with schizophrenia, we examined the rates and causes of mortality in older adults with schizophrenia who take ...
Raphaëlle Haddad +7 more
doaj +2 more sources
Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database [PDF]
Scientific ReportsRhabdomyolysis is a potentially fatal adverse reaction mainly caused by certain medications. Few real-world studies have shown a clear association between atypical antipsychotics and rhabdomyolysis.
Yi Yin, Jie Jiang, Youpeng Jin
doaj +2 more sources
Efficacy of atypical antipsychotics in schizophrenia patients: effects of 5-HTR SNPs [PDF]
Annals of General PsychiatryThe 5-hydroxytryptamine receptor (5-HTR) is a key protein responsible for the effects of 5-hydroxytryptamine (5-HT) and an important target for many antipsychotics.
Keying Liu +8 more
doaj +2 more sources
Journal of Medical Sciences, 2015 Background: Concerns regarding stroke safety associated with the use of atypical antipsychotics among dementia patients have been raised. Although observational studies have found conflicting associations of stroke risk with the use of typical or ...
Meng-Ting Wang +5 more
doaj +2 more sources
Eurasian Journal of Medicine, 2011 Objective: Although atypical antipsychotics are well-tolerated and effective treatment options for schizophrenia, they have metabolic side effects, including weight gain and increased risk of Type II Diabetes Mellitus (DM).
Elif Oral +5 more
doaj +2 more sources
Characteristics of eye disorders induced by atypical antipsychotics: a real-world study from 2016 to 2022 based on Food and Drug Administration Adverse Event Reporting System [PDF]
Frontiers in PsychiatryBackgroundCommon atypical antipsychotics include risperidone, paliperidone, olanzapine, lurasidone, quetiapine, clozapine, aripiprazole, ziprasidone, asenapine, brexpiprazole, and cariprazine.
Chao Mu, Li Chen
doaj +2 more sources
Seeing beyond the norm: Unveiling ocular complications with atypical antipsychotics
Industrial Psychiatry JournalPsychotropic medications, particularly antipsychotics, are known to elicit various adverse effects, with ocular complications being underreported yet significant. This case series presents three instances where atypical antipsychotics, namely Risperidone,
Akansha Bhardwaj +3 more
doaj +2 more sources
The Effect of Atypical Anti-psychotic Agents on Obesity and Glucose Metabolism [PDF]
Journal of Medicine and Life Science, 2021 Atypical antipsychotics are more effective than typical antipsychotics and have fewer side effects such as tardive dyskinesia and extrapyramidal symptoms; therefore, prescriptions of atypical antipsychotics are increasing.
Sang Ah Lee, Suk Ju Cho, Jae Cheol Moon
doaj +1 more source